CYP3A5 and chronic kidney disease: In view of the common occurrence of CYP3A5*3 polymorphism among Southeast Asian populations, it is important to understand the association of the gene polymorphism with antihypertensives, which are commonly used in CKD populations and play an important role in managing CKD (KDIGO, 2012).